Interleukin-17A Antagonist [EPC]

153067 reported adverse events

Drugs of this class: IXEKIZUMAB SECUKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-17A Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 25184
1 PSORIASIS 20828
2 PAIN 12404
3 ARTHRALGIA 11160
4 FATIGUE 7117
5 PRURITUS 7107
6 MALAISE 6698
7 PSORIATIC ARTHROPATHY 6404
8 INJECTION SITE PAIN 6280
9 RASH 6068
See all common reactions for Interleukin-17A Antagonist [EPC]

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND PSORIASIS 330 0.6721
1 LUPUS VULGARIS 97 0.5607
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 115 0.5349
3 RED BLOOD CELL SEDIMENTATION RATE 107 0.4131
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 183 0.4122
5 SWOLLEN JOINT COUNT INCREASED 380 0.3629
6 C-REACTIVE PROTEIN 84 0.3320
7 RHEUMATIC FEVER 471 0.3287
8 MACULE 654 0.2931
9 NAIL PSORIASIS 137 0.2890
See all enriched reactions for Interleukin-17A Antagonist [EPC]